Row circle Shape Decorative svg added to bottom
Elevating Our Communities With Every Interaction

Velocity is the world's leading integrated site organization.

Sponsors and CROs trust Velocity to deliver high-quality clinical trial data and patient care with unprecedented efficiency.

Simplify everything from site selection to study close-out

Velocity unifies operational processes to provide world-class sites, reliable enrollment, and predictably high performance for your trials.

+
Research sites across the U.S. and Europe
+
Investigators with diverse experience
+
Clinical trials conducted since 1986
U.S. Department of Health and Human Services (HHS) Officials Meet With Leaders to Discuss COVID-19 Vaccine Clinical Trials and Patient Recruitment
mother-and-child-2
Hallandale
caring african medical nurse comforting senior patient in office
jeff-leadership-team

The right sites.
The right investigators.
The right partner for you.

Strategically located to give you access to diverse specialty populations, Velocity's sites are supported by next-gen technologies and patient engagement capabilities. Welcome to recruitment and retention reimagined.

Row circle Shape Decorative svg added to bottom

Scale for a purpose: Supporting research programs worldwide

From the leading pharma companies, to the most pioneering biotech startups, Velocity supports those who are exploring new frontiers in human health.

Whether you’re ready to conduct a single-site study or a complex, high-volume clinical trial, contact Velocity.

News

Better Matches, Faster: How Agentic AI Is Changing Clinical Trial Feasibility

July 16, 2026

By Sweta Pittala, VP, Technology Portfolio Management At a Glance Responding to Requests for Proposal (RFPs) is one of the most labor-intensive processes in clinical trial operations. Velocity’s Feasibility Agent … Read more

Kris Kowdley, MD Featured in Ipsen’s ELSPIRE Trial Announcement

July 15, 2026

Congratulations to Ipsen on positive Phase IIIb results from the ELSPIRE trial evaluating IQIRVO® (elafibranor) in patients with Primary Biliary Cholangitis (PBC). The trial met its primary endpoint with statistical … Read more

The New AI Baseline… and How Sponsors Build an Advantage

July 7, 2026

By Nick Spittal, Chief Operations Officer, Velocity Clinical Research How many times have you heard the term AI this week? Sponsors are investing in it, CROs are building for it, … Read more

What It Actually Means to Be a Partner in Clinical Research

June 18, 2026

By Andrew Reina, Chief Revenue Officer I spent the better part of two decades on the CRO side of clinical research, which gives you a particular vantage point. You see … Read more

Row concave Shape Decorative svg added to top

Quality. Continuity. Velocity.